Skip to main content

Single Sided Deafness

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Cochlear
CochlearAustralia - Macquarie Park
1 program
Cochlear Nucleus Cochlear Implant SystemN/A1 trial
Active Trials
NCT01670006Completed10Est. Feb 2016
Oticon
OticonDenmark - Smørum
1 program
Cochlear implantN/A1 trial
Active Trials
NCT02966366Completed27Est. Mar 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OticonCochlear implant
CochlearCochlear Nucleus Cochlear Implant System

Clinical Trials (2)

Total enrollment: 37 patients across 2 trials

NCT02966366OticonCochlear implant

Tinnitus Treatment With Cochlear Implant in Single Sided Deafness

Start: Aug 2013Est. completion: Mar 201727 patients
N/ACompleted
NCT01670006CochlearCochlear Nucleus Cochlear Implant System

Implantation of the Cochlear® Nucleus® System in Adults With Single-Sided Deafness

Start: Oct 2012Est. completion: Feb 201610 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.